Sale!

Cultured AFB Antitubercular DST Rapid 11 Drugs Panel Test

2,710 د.إ

-10%

The “Cultured AFB Antitubercular DST Rapid 11 Drugs Panel Test” is a sophisticated diagnostic procedure available at DNA Labs UAE, designed to rapidly identify the drug susceptibility of Mycobacterium tuberculosis complex (MTBC) isolates. This test is crucial for the management of tuberculosis (TB), as it helps in determining the most effective drug regimen for treating the infection, especially in cases of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB).

The panel covers a comprehensive range of 11 drugs, ensuring a broad assessment of the bacterium’s resistance profile. By analyzing cultured samples of the AFB (Acid-Fast Bacilli), this test can accurately pinpoint which antitubercular drugs the TB strain is resistant to, thereby guiding healthcare professionals in tailoring the most appropriate and effective treatment plan for the patient.

Priced at 2710 AED, the test represents a significant investment in the accurate and expedited management of tuberculosis, a disease that continues to pose a significant public health challenge globally. Conducted at the state-of-the-art facilities of DNA Labs UAE, patients and healthcare providers can expect reliable and timely results, contributing to better treatment outcomes and the containment of TB spread.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CULTURED AFB ANTITUBERCULAR DST RAPID 11 DRUGS PANEL Test

Test Cost: AED 2710.0

Components:

  • Streptomycin
  • Isoniazid
  • Rifampicin
  • Ethambutol
  • Pyrazinamide
  • Clofazimine
  • Ethionamide
  • Capreomycin
  • Kanamycin
  • Amikacin
  • Ofloxacin

Price: 2710.0 AED

Sample Condition:

Submit pure growth of Mycobacterium tuberculosis complex on appropriate media in sterile screw capped container in a sealed plastic bag. Ship refrigerated OR when used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in the Laboratory from specimens already submitted will be processed for Antitubercular Sensitivity.

Report Delivery:

Sample daily by 3.30 pm; Report 21 days

Method:

Automated Fluorescent

Test Type:

Tuberculosis

Doctor:

Physician

Test Department:

Pre Test Information: No special preparation required

Test Details:

The CULTURED AFB ANTITUBERCULAR DST RAPID 11 DRUGS PANEL test is a diagnostic test used to determine the susceptibility of mycobacterial strains to various antitubercular drugs. It is primarily used for testing strains of Mycobacterium tuberculosis, the bacteria that causes tuberculosis. The test panel includes 11 different drugs commonly used in the treatment of tuberculosis, including isoniazid, rifampin, ethambutol, streptomycin, pyrazinamide, kanamycin, amikacin, capreomycin, moxifloxacin, ofloxacin, and ethionamide. These drugs belong to different classes and have different mechanisms of action against the bacteria. During the test, a culture of the mycobacterial strain is grown in the presence of the different drugs. The growth of the bacteria is then observed to determine if they are susceptible or resistant to each drug. This information helps guide the selection of appropriate drugs for the treatment of tuberculosis, as drug-resistant strains require different treatment regimens. The CULTURED AFB ANTITUBERCULAR DST RAPID 11 DRUGS PANEL test is important in the management of tuberculosis, as it helps healthcare providers choose the most effective treatment options for patients. It can also provide valuable information about the prevalence of drug-resistant strains in a particular population, which is important for public health planning and monitoring.

Test Name CULTURED AFB ANTITUBERCULAR DST RAPID 11 DRUGS PANEL Test
Components *Streptomycin*Isoniazid*Rifampicin *Ethambutol*Pyrazinamide *Clofazimine *Ethionamide*Capreomycin*Kanamycin *Amikacin *Ofloxacin
Price 2710.0 AED
Sample Condition Submit pure growth ofMycobacterium tuberculosis complexon appropriate media in sterile screw capped container in a sealed plastic bag. Ship refrigerated ORwhen used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in the Laboratory from specimens already submittedwill be processed for Antitubercular Sensitivity.
Report Delivery Sample Daily by 3.30 pm; Report 21 days
Method Automated Fluorescent
Test type Tuberculosis
Doctor Physician
Test Department:
Pre Test Information No special preparation required
Test Details

The CULTURED AFB ANTITUBERCULAR DST RAPID 11 DRUGS PANEL test is a diagnostic test used to determine the susceptibility of mycobacterial strains to various antitubercular drugs. It is primarily used for testing strains of Mycobacterium tuberculosis, the bacteria that causes tuberculosis.

The test panel includes 11 different drugs commonly used in the treatment of tuberculosis, including isoniazid, rifampin, ethambutol, streptomycin, pyrazinamide, kanamycin, amikacin, capreomycin, moxifloxacin, ofloxacin, and ethionamide. These drugs belong to different classes and have different mechanisms of action against the bacteria.

During the test, a culture of the mycobacterial strain is grown in the presence of the different drugs. The growth of the bacteria is then observed to determine if they are susceptible or resistant to each drug. This information helps guide the selection of appropriate drugs for the treatment of tuberculosis, as drug-resistant strains require different treatment regimens.

The CULTURED AFB ANTITUBERCULAR DST RAPID 11 DRUGS PANEL test is important in the management of tuberculosis, as it helps healthcare providers choose the most effective treatment options for patients. It can also provide valuable information about the prevalence of drug-resistant strains in a particular population, which is important for public health planning and monitoring.